A Phase 3, Two- Stage, Randomized, Multicenter, Open-Label Study Comparing Iberdomide, Daratumumab And Dexamethasone (Iberdd) Versus Daratumumab, Bortezomib, And Dexamethasone (Dvd) In Subjects With Relapsed Or Refractory Multiple Myeloma (Rrmm) (Excaliber-Rrmm)

  • Spencer, Andrew (Primary Chief Investigator (PCI))
  • Malherbe, Maturos (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date6/10/22 → 5/10/24

Keywords

  • Clinical trials
  • Myeloma